PTC Therapeutics, Inc. (PTCT)

PTC Therapeutics Revenue

PTC Therapeutics had revenue of $927.56M in the twelve months ending March 31, 2024, with 20.39% growth year-over-year. Revenue in the quarter ending March 31, 2024 was $210.12M, a -4.66% decrease year-over-year. In the year 2023, PTC Therapeutics had annual revenue of $937.82M with 34.20% growth.

• Revenue (ttm): $927.56M
• Revenue Growth: +20.39%
• P/S Ratio: 2.78
• Revenue / Employee: $932,219
• Employees: 995
• Market Cap: 2.58B USD

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2023	937.82M	239.02M	34.20%
Dec 31, 2022	698.80M	160.21M	29.75%
Dec 31, 2021	538.59M	157.83M	41.45%
Dec 31, 2020	380.77M	73.79M	24.04%
Dec 31, 2019	306.98M	42.25M	15.96%
Dec 31, 2018	264.73M	70.34M	36.19%
Dec 31, 2017	194.39M	111.69M	135.04%
Dec 31, 2016	82.71M	45.94M	124.95%
Dec 31, 2015	36.77M	11.52M	45.64%
Dec 31, 2014	25.25M	-9.45M	-27.24%
Dec 31, 2013	34.70M	750.00K	2.21%
Dec 31, 2012	33.95M	-71.47M	-67.80%
Dec 31, 2011	105.41M	-	-

Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.